d'Angeac AD - Search Results

1

CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses.

d'Angeac AD, Monier S, Pilling D, Travaglio-Encinoza A, Rème T, Salmon M. d'Angeac AD, et al. Eur J Immunol. 1994 Jul;24(7):1503-11. doi: 10.1002/eji.1830240707. Eur J Immunol. 1994. PMID: 7517872

2

Human mucosyl lymphocyte marker expression in synovial fluid lymphocytes of patient with rheumatoid arthritis.

Jorgensen C, Travaglio-Encinoza A, Bologna C, D'Angeac AD, Reme T, Sany J. Jorgensen C, et al. Among authors: d angeac ad. J Rheumatol. 1994 Sep;21(9):1602-7. J Rheumatol. 1994. PMID: 7799335

3

Jacalin, a lectin that inhibits in vitro HIV-1 infection, induces intracellular calcium increase via CD4 in cells lacking the CD3/TcR complex.

Lafont V, Dornand J, d'Angeac AD, Monier S, Alcover A, Favero J. Lafont V, et al. Among authors: d angeac ad. J Leukoc Biol. 1994 Oct;56(4):521-4. doi: 10.1002/jlb.56.4.521. J Leukoc Biol. 1994. PMID: 7930950

4

T-cell receptor V beta gene usage in rheumatoid synovial follicles.

Travaglio-Encinozal A, Dersimonian H, Jorgensen C, Romagné F, Sany J, D'Angeac AD, Brenner MB, Rème T. Travaglio-Encinozal A, et al. Among authors: d angeac ad. Ann N Y Acad Sci. 1995 Jul 7;756:201-3. doi: 10.1111/j.1749-6632.1995.tb44511.x. Ann N Y Acad Sci. 1995. PMID: 7645833 No abstract available.

5

T cell receptor gamma variable gene locus polymorphism in patients with rheumatoid arthritis.

Chaouni I, Lefranc MP, d'Angeac AD, Zanin C, Pellet F, Clot J, Combe B, Sany J, Rème T. Chaouni I, et al. Arthritis Rheum. 1992 Jul;35(7):756-60. doi: 10.1002/art.1780350707. Arthritis Rheum. 1992. PMID: 1352450

6

TCR V beta selection from a DRB1*401*0101 patient with rheumatoid arthritis complicated by a CD8+ T cell infiltrated rheumatoid pericarditis.

Travaglio-Encinoza A, Anaya JM, d'Angeac AD, Sany J, Rème T. Travaglio-Encinoza A, et al. Among authors: d angeac ad. J Rheumatol. 1994 Jul;21(7):1373-5. J Rheumatol. 1994. PMID: 7966093 No abstract available.

7

Inhibition of T cell apoptosis in the rheumatoid synovium.

Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN. Salmon M, et al. Among authors: d angeac ad. J Clin Invest. 1997 Feb 1;99(3):439-46. doi: 10.1172/JCI119178. J Clin Invest. 1997. PMID: 9022077 Free PMC article.

8

Accessory function of a small radioresistant spleen cell population in the generation of T-cell-mediated cytotoxicity.

D'Angeac AD, Reme T, Pla M, Colombani J. D'Angeac AD, et al. Cell Immunol. 1982 Mar 15;68(1):1-15. doi: 10.1016/0008-8749(82)90085-5. Cell Immunol. 1982. PMID: 6979397 No abstract available.

9

Stimulatory cells in the generation of T-cell-mediated cytotoxicity: potent stimulating activity of a small radioresistant spleen cells population (RSCs).

Reme T, D'Angeac AD, Radal M, Serrou B. Reme T, et al. Cell Immunol. 1981 Sep 15;63(2):335-48. doi: 10.1016/0008-8749(81)90013-7. Cell Immunol. 1981. PMID: 6974053 No abstract available.

10

Interleukin 2 (IL 2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL 2 receptor levels.

Miossec P, Elhamiani M, Chichehian B, D'Angeac AD, Sany J, Hirn M. Miossec P, et al. J Clin Immunol. 1990 Mar;10(2):115-20. doi: 10.1007/BF00918193. J Clin Immunol. 1990. PMID: 2338453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page